Clinical Investigator
Catherine Fullerton, M.D., M.P.H.
Massachusetts General Hospital
Total Trials
1
As PI
0
Completed
1
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
DRUG(2)
Mecamylamine
1 trial
not_applicable
massachusetts-general-hospitalVarenicline
1 trial
not_applicable
massachusetts-general-hospital2 unique interventions1 categories
Analytics
Trial Phases
No phase data
Trial Status
Completed1
Role Distribution
Other Roles1
Activity Timeline
Clinical Trials (1)
Study of the Effects of Mecamylamine and Varenicline in Schizophrenia
Cognition in Schizophrenia
Studydirector
Research Network
Collaboration Network
6 collaborators·5 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Massachusetts General Hospital
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
2 similar investigators found
Carol A Tamminga, MD
University of Texas Southwestern Medical Center
3 trials
Shared therapeutic areas:
Cognition in Schizophrenia
Similarity Score30%
A. Eden Evins, MD, MPH
Massachusetts General Hospital
9 trials
Shared therapeutic areas:
Cognition in Schizophrenia
Worked with same sponsors:
Massachusetts General HospitalNational Alliance for Research on Schizophrenia and Depression+1 more
Collaborated on 1 trial
Similarity Score14%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Study of the Effects of Mecamylamine and Varenicline in Schizophrenia
Cognition in Schizophrenia
All 1 trials loaded